Hytro Limited Secures £120k in Latest Funding Round, Valued at £11.9m

Hytro Limited, a West Byfleet-based innovator in Blood Flow Restriction (BFR) wearable technology, has successfully secured £120k in its latest funding round. This recent capital injection, with an allotment date of 2026-03-13 and a filing date of 2026-03-22, places the company's post-money valuation at an estimated £11.9m.

Incorporated on 2019-08-19, Hytro Limited specialises in the design and manufacture of integrated compression garments that utilise BFR technology. These performance-enhancing products are engineered to accelerate muscle growth and recovery, catering to a diverse clientele that includes professional athletes, elite sports teams, and fitness enthusiasts. The company currently operates with a team of 5 employees, focusing its efforts on developing and distributing its specialised sports goods.

This latest funding round marks another step in Hytro Limited's fundraising journey, demonstrating a consistent pattern of securing capital to fuel its growth and product development. The £120k raise contributes to a series of investments the company has attracted over recent years.

Looking back at previous funding activities, Hytro Limited has shown a steady progression in both the volume of capital raised and its overall valuation. In 2025, the company secured £292.5k on August 8, following an earlier raise of £425k on March 31. The year 2024 was also active for Hytro, with a significant raise of £458k on October 19, which saw its valuation reach £6.2m. Prior to this, several smaller rounds were completed in 2024, including £50k on June 10, valuing the company at £4.2m; another £50k on May 1, maintaining the £4.2m valuation; £50k on April 5, with a valuation of £4.1m; and £50k on March 3, at a valuation of £4m.

Further back, in late 2023, Hytro Limited also attracted notable investment. On December 23, 2023, the company raised £95k, holding a valuation of £4m. This was preceded by £137.4k on November 10, 2023, at a £3.9m valuation, and £61.2k on November 5, 2023, which valued the company at £3.7m. The consistent upward trajectory in valuation, from £3.7m in late 2023 to the current £11.9m, underscores investor confidence in Hytro's BFR technology and its market potential within the sports goods sector. This latest funding round will likely support the company's ongoing efforts in product innovation, market expansion, and scaling its operations to meet the growing demand for advanced athletic performance and recovery solutions.